Johnny Suijker
Mimetas (Netherlands)(NL)
Publications by Year
Research Areas
Bone Tumor Diagnosis and Treatments, Sarcoma Diagnosis and Treatment, 3D Printing in Biomedical Research, Connective tissue disorders research, Cancer-related molecular mechanisms research
Most-Cited Works
- → Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines(2015)103 cited
- → Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors(2015)94 cited
- → A Microfluidic 3D Endothelium-on-a-Chip Model to Study Transendothelial Migration of T Cells in Health and Disease(2021)76 cited
- → IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas(2017)73 cited
- → NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma(2017)42 cited
- → The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo(2015)38 cited
- → Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line(2016)33 cited
- → Phenotypic screening in Organ-on-a-Chip systems: a 1537 kinase inhibitor library screen on a 3D angiogenesis assay(2023)20 cited
- → Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation(2022)8 cited
- → Proteasomal insensitivity of apoptin in tumor cells(2012)6 cited